President's Corner - Exome Tests are Not All the Same
Many think that exome sequencing tests from different labs are basically the same and that the only important differentiator is price. In reality, exome (and genome) sequencing tests vary greatly among labs.
PGxome®-Based Tests Validated for Copy Number Variants
We are pleased to announce that all of PreventionGenetics’ PGxome® (whole exome sequencing) based sequencing tests are now validated for copy number variant (CNV) detection. In many cases, this will alleviate the need for chromosomal microarray (CMA) or gene-centric array Comparative Genomic Hybridization(aCGH) tests, thereby increasing the value for you and your patients!
PreventionGenetics announces integration with FDNA's deep learning platform, Face2Gene to increase the diagnostic power of genetic testing
November 29, 2017, Marshfield, WI – PreventionGenetics today announces integration of their genetic testing and interpretation services with FDNA’s (www.fdna.com) Face2Gene suite of applications (www.face2gene.com).
The integration with Face2Gene increases the diagnostic power of PreventionGenetics’ genetic testing using artificial intelligence and computer vision technology, which highlights genetic variants that are highly correlated with disease and the patient’s clinical phenotype.